| Literature DB >> 32012855 |
Irene K Sigmund1,2, Jamie Ferguson1, Geertje A M Govaert3, David Stubbs1, Martin A McNally1.
Abstract
This prospective study compared bifocal acute shortening and relengthening (ASR) with bone transport (BT) in a consecutive series of complex tibial infected non-unions and osteomyelitis, for the reconstruction of segmental defects created at the surgical resection of the infection. Patients with an infected tibial segmental defect (>2 cm) were eligible for inclusion. Patients were allocated to ASR or BT, using a standardized protocol, depending on defect size, the condition of soft tissues and the state of the fibula (intact or divided). We recorded the Weber-Cech classification, previous operations, external fixation time, external fixation index (EFI), follow-up duration, time to union, ASAMI bone and functional scores and complications. A total of 47 patients (ASR: 20 patients, BT: 27 patients) with a median follow-up of 37.9 months (range 16-128) were included. In the ASR group, the mean bone defect size measured 4.0 cm, and the mean frame time was 8.8 months. In the BT group, the mean bone defect size measured 5.9cm, and the mean frame time was 10.3 months. There was no statistically significant difference in the EFI between ASR and BT (2.0 and 1.8 months/cm, respectively) (p = 0.223). A total of 3/20 patients of the ASR and 15/27 of the BT group needed further unplanned surgery during Ilizarov treatment (p = 0.006). Docking site surgery was significantly more frequent in BT; 66.7%, versus ASL; 5.0% (p < 0.0001). The infection eradication rate was 100% in both groups at final follow-up. Final ASAMI functional rating scores and bone scores were similar in both groups. Segmental resection with the Ilizarov method is effective and safe for reconstruction of infected tibial defects, allowing the eradication of infection and high union rates. However, BT demonstrated a higher rate of unplanned surgeries, especially docking site revisions. Acute shortening and relengthening does not reduce the fixator index. Both techniques deliver good functional outcome after completion of treatment.Entities:
Keywords: Ilizarov; acute shortening; bifocal; bone transport; distraction; infection; non-union; outcome; tibia
Year: 2020 PMID: 32012855 PMCID: PMC7074086 DOI: 10.3390/jcm9020279
Source DB: PubMed Journal: J Clin Med ISSN: 2077-0383 Impact factor: 4.241
Figure 1Acute shortening with relengthening. (a) Open fracture of tibia treated with early debridement, IM nailing and flap cover. Presented at three months, with a discharging sinus and exposed medial tibial bone. (b) A 2.5 cm resection was required. The tibia was acutely shortened to good bone contact and the flap reused to cover the defect. (c) Distraction was performed at 1 mm per day through the proximal corticotomy (b) and continued until equal leg length was achieved (at four weeks after surgery). (d) Eight months after surgery, the tibia was solidly healed with good alignment and no evidence of infection.
Figure 2Bone Transport. (a) Previous open fracture of distal tibia, treated with internal fixation. The wound broke down and he was referred with a mobile infected non-union. Preoperative AP x-ray shows that the lateral tibial plate has broken at the non-union. (b) Four centimetre resection of the non-union after removal of the infected tibial plate. The fibula was intact and well aligned, so a bone transport was preferred. (c) Twenty-six days after surgery. The proximal corticotomy is distracted at 1 mm per day. (d) Six weeks after docking. No surgery was required to secure union at the docking site. (e) Four months after frame removal with well consolidated docking site, regenerate and good alignment.
Demographic data and surgical features of the study cohort stratified in groups with acute shortening and relengthening (ASR) and bone transport (BT). Values in bold are statistically significant.
| Demographic Data | ASR ( | BT ( | |
|---|---|---|---|
| Patient age (mean) | 48.9 (21–78) | 50.9 (29–75) | 0.738 |
| Bone Defect (cm) | 4.0 (2–5) | 5.9 (3–10) | 0.007 |
| Prior Surgeries per patient | 2.9 (1–5) | 2.7 (1–6) | 0.858 |
| Sinus tract | 8 | 9 | 0.761 |
| Muscle flap | 7 | 10 | 1.000 |
| EF time (months) | 8.8 (5–16) | 10.3 (7–17) | 0.064 |
| EFI (months/cm) | 2.0 (1.3–2.8) | 1.8 (0.9–2.7) | 0.223 |
| Weber–Cech type ( | |||
| Type C | 1 (5) | 0 (0) | |
| Type D | 4 (20) | 4 (15) | |
| Type E | 3 (15) | 5 (19) | |
| Type F | 12 (60) | 18 (67) |
A statistically significant difference between both study groups was demonstrated for the magnitude of bone defect (p = 0.007) with larger defects in the BT group. The absolute external fixator time was shorter in the ASR group, but it was not statistically significant (p = 0.064).
Outcome of the treatment of infected tibial segmental defect in the acute shortening/relengthening (ASR) group and the bone transport (BT) group.
| Total | ASR | BT | ||
|---|---|---|---|---|
| Infection-free | 47 (100) | 20 (100) | 27 (100) | 1.000 |
| Union without further surgery | 35 (74) | 18 (90) | 17 (63) | 0.047 |
| Unplanned Reoperation during EF treatment including docking site | 18 (38) | 3 (15) | 15 (56) | 0.006 |
| Unplanned Reoperation during EF treatment excluding docking site | 5 (11) | 3 (15) | 2 (7) | 0.638 |
| Unplanned Reoperation after EF removal | 13 (28) | 3 (15) | 10 (37) | 0.114 |
| Refracture after EF removal | 3 (7) | 2 (11) | 1 (4) | 0.575 |
| Final Infection-free union | 47 (100) | 20 (100) | 27 (100) | 1.000 |
Figure 3Results of the Association for the Advancement of Methods of Ilizarov (ASAMI) bone classification in the acute shortening/relengthening (ASR) and bone transport (BT) group. There was no statistically significant difference between the groups (p = 0.682). The y-axis gives the absolute numbers.
Figure 4Results of the ASAMI functional classification in the acute shortening/relengthening (ASR) and bone transport (BT) group. There was no statistically significant difference between the groups (p = 0.705). The y-axis gives the absolute numbers.
Surgeries during and after external fixator (EF) treatment in the acute shortening/relengthening (ASR) group and the bone transport (BT) group.
| Total | ASR | BT | ||
|---|---|---|---|---|
|
| ||||
| Fibular Division | 1 (2) | 1 (5) | 0 (0) | 0.426 |
| Insertion of further pins | 1 (2) | 1 (5) | 0 (0) | 0.426 |
| Tethered pin site release | 1 (2) | 1 (5) | 0 (0) | 0.426 |
| Bone grafting only | 4 (9) | 0 (0) | 4 (15) | 0.126 |
| Freshening of docking site | 3 (6) | 0 (0) | 3 (11) | 0.251 |
| Docking Site Realignment | 4 (9) | 0 (0) | 4 (15) | 0.126 |
| Re-Corticotomy | 2 (4) | 0 (0) | 2 (7) | 0.500 |
| BMP only | 2 (4) | 0 (0) | 2 (7) | 0.500 |
|
| ||||
| Plate only | 4 (9) | 0 (0) | 4 (15) | 0.126 |
| Plating and bone grafting | 1 (2) | 1 (5) | 0 (0) | 0.426 |
| Plating and BMP | 1 (2) | 0 (0) | 1 (4) | 1.000 |
| EF reapplication | 1 (2) | 1 (5) | 0 (0) | 0.426 |
| Intramedullary Nail | 4 (9) | 1 (5) | 3 (11) | 0.626 |
| Ankle Fusion | 2 (4) | 0 (0) | 2 (7) | 0.500 |
|
| 31 | 6 | 25 |
|
NOTE. The values given are the number of cases, with percentage in parentheses. Values in bold are statistically significant. EF = external fixator, BMP = Bone Morphogenic Protein.
Results of comparative trials in the literature.
| Khan et al. [ | Eralp et al. [ | Testworth et al. [ | Present Study | |||||
|---|---|---|---|---|---|---|---|---|
| Study design | prospective | retrospective | retrospective | prospective | ||||
| Number of patients | 24 | 74 | 42 | 47 | ||||
| Procedure | ASR | BT | ASR | BT | ASR | BT | ASR | BT |
| Mean bone defect (cm) | 3.3 (in all patients) | 5.9 | 5.3 | 5.8 | 7.0 | 4.0 | 5.9 | |
| Mean EF time (months) | 8 | 9 | 10 | 10 | 13 | 8.8 | 10.3 | |
| Mean EFI (m/cm) | 4.2 | 1.6 | 2.1 | 1.7 | 1.8 | 2.0 | 1.8 | |
| ASAMI functional | 7 excellent | 1 excellent | 34 excellent | 22 excellent | 14 excellent | 14 excellent | 12 excellent | 19 excellent |
| ASAMI bone | 6 excellent | 5 good | 35 excellent | 21 excellent | 19 excellent | 15 excellent | 18 excellent | 22 excellent |